A betamimetic drug and human fetal lung maturation.
In a double-blind and randomized study the administration of a betamimetic drug to the mother from week 33 to 35 produces a significant increase in amniotic fluid palmitic acid levels. We suggest that the administration of a betamimetic drug during pregnancy to the mother can be useful in producing an acceleration of the fetal lung maturation.
D000328:Adult; D000653:Amniotic Fluid / Q000378:metabolism; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology*; D010169:Palmitic Acids / Q000378:metabolism; D011247:Pregnancy; D011897:Random Allocation; D012312:Ritodrine / Q000627:therapeutic use*
D010169:Palmitic Acids; D012312:Ritodrine